The Jikei University School of Medicine · Graduate School of Medicine / Faculty of Medicine · 講師

Research keywordspsoriasis inflammation・adalimumab・infliximab・generalized pustular psoriasis・IL-33・CCL27・keratinocytes・adiponectin・matrix metalloproteinases

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Calcipotriol induces the production of CTACK/CCL27, one of the potential suppressive factors in psoriasis inflammation.2021
• Results of a retrospective study on the efficacy and safety of adalimumab 80 mg administrated every other week in patients with psoriasis at a single Japanese institution.2019
• Adalimumab administration after infliximab therapy is a successful treatment strategy for generalized pustular psoriasis.2017
• Case of generalized pustular psoriasis exacerbated during pregnancy, successfully treated with infliximab.2016

• Official profile